Several studies have reported evidence of the role of TPD52 in various signaling pathways of cancers, i.e., in the PI3K/Akt signaling pathway (14), protein kinase B/Akt signaling pathway (15), and nuclear factor-κB transactivation (16). Here, AKT1 is linked to cancer.